Biat Group develops and commercializes biotech assets, mainly new approach methods (NAMs) for in-vivo toxicity and efficacy regulatory and non-regulatory testing and proprietary split-inteins with unique applications in advanced therapies among others
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
